CRISPR Therapeutics Names Siva Sakhamuri Chief Technical Officer

PUBT · 11/02 13:05
CRISPR Therapeutics Names Siva Sakhamuri Chief Technical Officer
  • CRISPR Therapeutics appointed Sivakesava (Siva) Sakhamuri chief technical officer, effective immediately.
  • Sakhamuri joins from Orna Therapeutics, where he served as chief technical officer since 2024, bringing about 30 years of manufacturing leadership experience.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CRISPR Therapeutics AG published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611020800PRIMZONEFULLFEED9867638) on November 02, 2026, and is solely responsible for the information contained therein.